Other Events ·
China SXT Pharmaceuticals cancels $3M private placement of shares and warrants
SXTCChina SXT Pharmaceuticals, Inc.
On October 7, 2026, China SXT Pharmaceuticals entered into a Securities Purchase Agreement for a private placement of 3 million Class A ordinary shares and warrants to purchase an additional 3 million shares. The offering was intended to raise $3 million in gross proceeds from non-U.S. persons under Regulation S. However, on October 8, 2026, the company and the purchasers agreed to terminate the agreement prior to closing. No shares or warrants were issued, and all obligations under the Securities Purchase Agreement were terminated. China SXT Pharmaceuticals operates in the pharmaceutical industry.